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A B S T R A C T
An aberrant immunologic mechanism has been suggested to be involved in the pathogenesis of endometri-
osis. Genetic alterations in the vitaminD receptor gene (VDR)may lead to important defects in gene activation
that principally affect immune function. We have hypothesized a possible relationship between endometri-
osis and/or infertility and the VDR polymorphisms (ApaI, TaqI, FokI, and BmsI). The study was a case–control
study including 132womenwith endometriosis-related infertility, 62womenwith idiopathic infertility, and
133 controls. VDR polymorphisms were studied by restriction fragment length polymorphism. We found
relatively similar VDR polymorphism genotype frequencies in cases and controls. When patients with
minimal/mild and moderate/severe endometriosis were studied separately, no difference was found. When
we compared infertile groups with and without endometriosis there was no statistically signiﬁcant differ-
ence. The data suggest that VDR polymorphisms did not play an important role in the pathogenesis of
endometriosis and/or infertility in the Brazilian women studied.
 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
Open access under the Elsevier OA license.
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i1. Introduction
Endometriosis is a common estrogen-dependent gynecologic
disease, deﬁned as the growth of endometrial tissue outside the
uterine cavity, that often results in a vast array of gynecologic
problems, including dyspareunia, dysmenorrhea, pelvic pain,
and infertility [1]. Susceptibility to endometriosis depends on a
complex interaction of immunologic, genetic, and hormonal fac-
tors [2,3].
Numerous hypotheses have been put forward to explain the
presence of ectopic endometrial tissue and stroma. Levander [4]
attempted to link 2 previous theories: metaplasia proposed by
Meyer [5] and retrograde tubal endometrial reﬂux proposed by
Sampson [6]. The presence of this abnormal menstrual reﬂux
would irritate the peritoneum. In defending itself, the peritoneum
would secrete activating and growth factors, which facilitate im-
plantation and growth and could thus induce metaplasia [4]. This
unifying theory is supported by modern immunologic concepts.
The immune system participates in the homeostasis of the perito-
neal cavity. Modiﬁcations in the peritoneal cavity functioning have
been advanced to explain endometriosis and its consequences
[7,8].
Some authors have suggested that endometriosis may have an
autoimmune component because it is often associatedwith the pres-
ence of antinuclear, antiphospholipid, and antiendometrial autoanti-* Corresponding author.
E-mail address: bianca.bianco@hotmail.com (B. Bianco).
0198-8859/11 2011 American Society for Histocompatibility and Immunogenetics. Pub
doi:10.1016/j.humimm.2011.01.006bodies aswell as an abrogated cell-mediated immunity reactionman-
ifested, for example, by decreased activity of natural killer cells and
cytotoxicT lymphocytes [7–9].Genetic factorsplayarole in thepatho-
genesis of endometriosis [3,10] and autoimmunity genes are there-
fore reasonable candidate genes for endometriosis [11].
Vitamin D is a hormone that has essential roles in endocrine
functions, regulating cell replication, and other metabolic path-
ways, such as those involved in immune response. Vitamin D sup-
presses lymphocyte proliferation and immunoglobulin synthesis
and inhibits the action of proinﬂammatory transcription factors
and the production of different cytokines, such as interleukin 2 and
interleukin 12, among others [12]. Most of the biologic activities of
vitamin D are mediated by a high-afﬁnity receptor that acts as a
transcription factor activated by the ligand receptor gene of vita-
min D [VDR; OMIM 601769). VDR, located on chromosome 12
12q13.11), is a member of the family of steroid receptors that
ediates the effects of vitamin D in regulating the transcription of
ultiple genes [13] The VDR gene is expressed in most cells of the
mmune system, including CD4 and CD8, as well as antigen-
presenting cells, macrophages, and dendritic cells; these cells also
possess the ﬁrst hydroxylase, which catalyzes the synthesis of
active vitamin D [14].
Genetic alterations in the VDR gene may lead to important
defects in gene activation principally affecting calcium metabo-
lism, cell proliferation, and immune function. The function of the
VDR gene is inﬂuenced by several genetic polymorphisms asso-
ciated with susceptibility to a range of diseases, such as osteoar-
lished by Elsevier Inc. Open access under the Elsevier OA license. 
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F.L. Vilarino et al. / Human Immunology 72 (2011) 359–363360thritis, diabetes, cancer, rheumatoid arthritis, and Graves dis-
ease [15].
In addition, vitamin D has been reported to increase respon-
siveness to estradiol and is used in osteoporosis treatment of
postmenopausal women [16]. Thus, because endometriosis is an
strogen-dependent disease, serum levels of vitamin D associ-
ted with polymorphisms in its receptor gene could increase
isease susceptibility.
Based on this observation, we have hypothesized the existence
f a relationship between endometriosis and/or infertility and
olymorphisms (ApaI, TaqI, FokI, and BmsI) of the vitamin D recep-
tor gene.
2. Subjects and methods
2.1. Patients
Three hundred seventy-four infertile women with endometrio-
sis were selected to participate in the study. From these patients,
132 infertile women with endometriosis (mean age, 35.1  3.9
ears) from the Endometriosis Outpatient Clinic of the Human
eproduction Service of the Faculdade de Medicina do ABC
FMABC) were studied once they met the criteria selection. The
tudied women were diagnosed with endometriosis by laparos-
opy and classiﬁed according to the American Society for Repro-
uctive Medicine [17] with histologic conﬁrmation of disease.
omen with acute or chronic medical conditions, especially auto-
mmune diseases, were excluded. In the endometriosis group, dis-
ase stagewasminimal/mild (stage I and II) in 72 cases (54.5%) and
oderate/severe (stage III and IV) in 60 cases (45.5%). Sixty-two
omen with idiopathic infertility (mean age, 35.7  5.0 years)
were screened at the Human Reproduction Service of the FMABC.
For the control group, 133 fertile women (mean age, 39.7  3.2
years) without autoimmune diseases were selected from the Fam-
ily PlanningOutpatient Clinic of the FMABC among a group submit-
ted for tubal ligation andwith conﬁrmed absence of endometriosis.
The cause of infertility was investigated according to the mini-
mum propedeutic procedure for infertile couples: hormonal and
biochemistry proﬁle, testing for sexually transmitted diseases, im-
aging examinations, investigation of genetic and/or immunologic
abnormalities, semen analysis, hysterosalpingography, hysteros-
copy, and laparoscopy (laparoscopy was performed in all women
up to 36 years old as well as in patients over 36 years old whenever
there were symptoms or abnormalities on imaging examinations).
In the absence of abnormalities in any of these exams, infertility
was considered idiopathic. Women with endometriosis who did
not achieve pregnancy after at least 6 natural or induced cycles
following laparoscopy were considered infertile. Women with
partners having any male factors associated with infertility were
excluded from the study.
Clinical data and peripheral blood samples were collected only
after the objectives of the study were explained and signed in-
formed consent was obtained, as approved by the Research Ethics
Committee of the Faculdade de Medicina do ABC.
Table 1
VDR polymorphisms and respective primers, restriction enzymes, and annealing te
Polymorphism rs Location Primer
ApaI
G1025-49T
11168271 Exon 2 F: CAG AG
R: GCA AC
TaqI
T1056C
731236 Exon 9 F: CAG AG
R: CAC TT
FokI
T2C
10735810 Exon 9 F: AGC TG
R: ATG GA
BmsI 1544410 Intron 8 F: AACCA
G1024283A R: AACCAGCGG2.2. Molecular analysis
Peripheral blood was collected from each patient and control
in an EDTA-containing tube. Genomic DNA was extracted from
peripheral blood lymphocytes according to Lahiri and Num-
berger [18].
The VDR gene polymorphisms were studied by restriction frag-
ment length polymorphism PCR, according to the protocol of
Gy×rffy et al. [19], with modiﬁcations. In general, the PCR proce-
dure was carried out in a total volume of 25-L reaction mixture
containing 10 reaction buffer (500 mM KCl, 100 mM Tris–Cl; pH
8.3), 2.5mMMgCl2, 0.8mMdNTP, 2.0 U Taq polymerase, and 50 nM
f each primer (sense and antisense). The cycling proﬁle consisted
f denaturation at 95C for 30 seconds; annealing temperature
aried according to polymorphism (Table 1), and extension was at
2C for 30 seconds, except for the ﬁrst cycle, when denaturation
as extended to 5minutes. The PCR product was digestedwith 5 U
BmsI and FokI) or 10 U (ApaI and TaqI) of the restriction enzyme
New England Biolabs, Ipswich, MA), and the reaction mixture was
ncubated at 65C for 15 minutes. The digestion product was sub-
ected to electrophoresis on a gel containing 2% agarose stained
ith ethidium bromide and visualized under ultraviolet light.
A random subset (20% of samples) was also evaluated by
quantitative PCR to conﬁrm the results of commercially available
BmsI (rs15444410) and TaqI (rs731236) polymorphism. Taqman
primers and probes for BmsI and TaqI polymorphisms were used
C_8716062_10 and C_2404008_10, respectively; Applied Biosys-
ems, Foster City, CA). Assays were performed with Taqman Uni-
ersal Master Mix (Applied Biosystems, Foster City, CA) with 50 ng
f DNA per reaction. PCR conditions were as recommended by the
anufacturer: initial denaturation at 95C (15 minutes), followed
y 40 denaturation cycles at 95C (15 seconds) and a ﬁnal anneal-
ng/extension cycle at 60C (1 minute).
.3. Statistical analysis
Statistical analyses were carried out using SPSS for Windows
1.0 (SPSS, Inc., Chicago, IL). The 2 test was used to compare allele
nd genotype frequencies between groups, to estimate Hardy–
einberg equilibrium, and to calculate the power of the test. The
dds ratio (OR) and range with 95% conﬁdence interval (95% CI)
ere calculated for the presence of the reference genotype using a
ogistic regression model. The association between the combined
enotypes of VDR gene polymorphisms and risk of infertility-
elated endometriosis was also evaluated by the study of haplo-
ypes using Haploview software version 4.1 (http://www.hapmap.
rg). All p values were two-tailed, and 95% CIs were calculated. A p
value  0.05 was considered statistically signiﬁcant.
3. Results
The genotype and allele distributions of ApaI, TaqI, FokI, and
BmsI polymorphisms ofVDR gene in infertilewomenwith endome-
triosis, womenwith idiopathic infertility, and controls are summa-
rized in Table 2.
tures
Restriction
enzyme
Annealing
temperature (C)
GAC AGG GAG CAA
CAT GGC TGA GGT CTC
ApaI 68
GAC AGG GAG CAA
CAC AAG GGG CGT TAG C
TaqI 68
TGG CAC TGA CTC TGC TCT
A CCT TGC TTC TTC TCC CTC
FokI 60
TACAAGTACCGCGTCAGTGA BmsI 62mpera
C ATG
T CCT
C ATG
C GAG
G CCC
A AC
AGACGAAGAGGTCAAGGG
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F.L. Vilarino et al. / Human Immunology 72 (2011) 359–363 361We found relatively similar VDR polymorphism genotype fre-
uencies in cases and controls and we did not observe any associ-
tion between polymorphisms in ApaI, TaqI, FokI, and BmsI and
endometriosis risk in endometriosis-related infertility or idio-
pathic infertile groups.Whenpatientswithminimal/mild endome-
triosis and moderate/severe endometriosis were studied sepa-
rately, no difference was found for any VDR polymorphism. When
we compared infertile groups with and without endometriosis
there was no statistically signiﬁcant difference related to the stud-
ied polymorphism frequency.
Statistical analyses showed that the genotype distribution in
endometriosis-related infertility, idiopathic infertility, and control
groups for all polymorphisms studied were in Hardy–Weinberg
equilibrium. Haplotype analysis showed that none of the VDR hap-
lotypes was associated with the endometriosis-related infertility
sample (Fig. 1). The power of the test calculated was 0.50 ( 
0.05) to the endometriosis-related infertility group.
4. Discussion
We did not ﬁnd a signiﬁcant difference in the frequencies of the
VDR polymorphisms either between infertile women with endo-
metriosis and controls or between idiopathic infertile women and
controls. To our knowledge, this is the ﬁrst study in the literature to
investigate the association between VDR polymorphisms (ApaI,
TaqI, FokI, and BmsI) and endometriosis and/or infertility.
Single nucleotide polymorphisms are common in the human
genomeandoftenprovide correlative evidence for the involvement
of speciﬁc genes in human disease. A polymorphism is a genetic
variant that appears in at least 1% of the population. Changes in the
regulatory parts of the gene could affect the degree of expression of
the gene and thus the levels of the protein. For instance, changes
in the 5= promoter of the VDR gene can affect mRNA expression
patterns and levels, whereas 3= untranslated region sequence vari-
Table 2
Genotype and allele frequencies of VDR polymorphisms ApaI, TaqI, BmsI, and FokI in
VDR polymorphism n Genotypes
n (%) n (%)
ApaI
G1025-48T
GG GA
Endometriosis-associated infertility patients 132 44 (33.4) 72 (54.5
Minimal/mild endometriosis 72 21 (29.1) 41 (57.0
Moderate/severe endometriosis 60 23 (38.3) 31 (51.7
Idiopathic infertile patients 62 33 (35.5) 29 (46.8
Controls 133 49 (36.8) 67 (50.4
TaqI
T1056C
TT TC
Endometriosis-associated infertility patients 132 55 (41.7) 62 (47.0
Minimal/mild endometriosis 72 31 (43.1) 34 (47.2
Moderate/severe endometriosis 60 24 (40.0) 28 (46.7
Idiopathic infertile patients 62 20 (32.2) 30 (48.4
Controls 133 50 (37.6) 71 (53.4
FokI
T2C
TT TC
Endometriosis-associated infertility patients 132 60 (45.5) 61 (46.2
Minimal/mild endometriosis 72 30 (41.7) 33 (45.8
Moderate/severe endometriosis 60 30 (50.0) 28 (46.7
Idiopathic infertile patients 62 31 (50.0) 28 (45.2
Controls 133 59 (44.4) 64 (48.1
BmsI
G1024283A
GG GA
Endometriosis-associated infertility patients 132 53 (40.1) 69 (52.3
Minimal/mild endometriosis 72 30 (41.6) 37 (51.4
Moderate/severe endometriosis 60 23 (38.3) 32 (53.3
Idiopathic infertile patients 62 24 (38.7) 34 (54.8
Controls 133 59 (44.4) 66 (49.6
OR  odds ratio; CI conﬁdence interval.
aVersus control group.
bVersus idiopathic infertile group.ations can affect mRNA stability and protein translation efﬁciency
p[15]. There is not much information regarding how the polymor-
phisms affect vitamin D receptor transcription. The VDR FokI poly-
morphism in exon 2 leads to an alternative transcription initiation
site, resulting in a VDR protein with the addition of 3 amino acids.
The VDR BsmI, TaqI, and ApaI polymorphisms have no established
functional role yet [20].
In animal and cell culture studies, tolerogenic dendritic cells are
nduced by active vitamin D treatment and promote the induction
f Tregs, regulatory T cells that are critical for maintaining immune
olerance, which are suggested to prevent autoimmune diseases
en with endometriosis, women with idiopathic infertility, and controls
Alleles pa OR (95% CI) pb
n (%) n (%) n (%)
AA G A
16 (12.1) 160 (60.6) 104 (39.4) 0.806 1.06 (0.75–1.51) 0.823
10 (13.9) 83 (57.7) 61 (42.3) 0.446 1.20 (0.79–1.81) 0.920
6 (10.0) 77 (64.2) 43 (35.8) 0.777 0.91 (0.58–1.43) 0.471
11 (17.7) 73 (58.9) 51 (41.1) 0.631 1.14 (0.74–1.76)
17 (12.8) 165 (62.0) 101 (38.0)
CC T C
15 (11.3) 172 (65.1) 92 (34.9) 0.841 0.96 (0.67–1.37) 0.124
7 (9.7) 96 (66.7) 48 (33.4) 0.654 0.90 (0.59–1.38) 0.112
8 (13.3) 76 (63.4) 44 (36.6) 1.0 1.04 (0.67–1.63) 0.335
12 (19.3) 70 (56.4) 54 (43.5) 0.195 1.39 (0.90–2.14)
12 (9.0) 171 (64.3) 95 (35.7)
CC T C
11 (8.3) 181 (68.5) 83 (31.5) 1.0 0.99 (0.69–1.43) 0.493
9 (12.5) 93 (64.6) 51 (35.4) 0.497 1.19 (0.77–1.82) 0.203
2 (3.3) 88 (73.3) 32 (26.7) 0.393 0.79 (0.49–1.27) 1.0
3 (4.8) 90 (72.6) 34 (27.4) 0.475 0.82 (0.51–1.31)
10 (7.5) 182 (68.4) 84 (31.6)
AA G A
10 (7.6) 175 (66.3) 89 (33.7) 0.537 1.14 (0.79–1.64) 0.920
5 (7.0) 97 (67.4) 47 (32.6) 0.791 1.09 (0.70–1.68) 0.920
5 (8.4) 78 (65.0) 42 (35.0) 0.488 1.21 (0.77–1.91) 1.0
4 (6.5) 82 (66.1) 42 (33.9) 0.631 1.15 (0.73–1.81)
8 (6.0) 184 (69.2) 82 (30.8)
Fig. 1. Graphical representation of the linkage disequilibrium structure of the VDR
aplotype block, obtained with Haploview v. 4.1 software. Squares represent the
airwise calculation of r2 (top) and D’ (bottom) in the female control cohort (values
ithin the squares, 100) for each combination of single nucleotide polymor-
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F.L. Vilarino et al. / Human Immunology 72 (2011) 359–363362because of their immunosuppressive activity [21,22]. Prietl et al.
[23] demonstrated that vitaminD intake signiﬁcantly increased the
percentage of Tregs in the peripheral circulation.
The possible link between endometriosis and the vitamin D
system has been poorly investigated in the past. The ﬁrst observa-
tion was reported by Hartwell et al. [24], who observed higher
serum levels of 1,25-dihydroxyvitamin D3 and similar levels of
25-hydroxyvitamin D3 in a small group of women with endome-
triosis compared with controls. Recently, Vigano et al. [25] demon-
strated that human endometrium can be included among those
sites capable of extrarenal synthesis of active vitamin D. The en-
zyme that catalyzes the synthesis of 1,25-dihydroxyvitamin D3,
1a-hydroxylase, is expressed in both eutopic and ectopic endome-
trium and its expression is enhanced in the eutopic endometrium of
womenwith endometriosis. Measurement of 1,25-dihydroxyvitamin
D3 levels in the supernatant of endometrial cells treated with 25-
hydroxyvitamin D3 conﬁrmed that endometrium represents a site
of local conversion from the precursor to the active form.
Somigliana et al. [26] studied serum levels of 25-hydroxyvitaminD3,
1,25-dihydroxyvitamin D3, and Ca2 by radioimmunoassay in 87
omen with endometriosis and 53 controls. The authors observed
hat the levels of 25-hydroxyvitamin D3 were signiﬁcantly in-
reased in the serum of women with endometriosis. A biologic
radient indicating more striking differences in patients with ad-
anced stages was also noted, resulting in the conclusion that
ndometriosis is associated with higher serum levels of vitamin D.
In a recent study, Faserl et al. [27] identiﬁed differences in
protein expression in serum that might shed light on the patho-
physiology of endometriosis. The authors found 25 protein spots
with a signiﬁcant difference in abundance between women with
endometriosis and controls, including acute-phase proteins and
complement components. The abundance of vitamin D-binding
protein was higher in all endometriosis pools compared with the
control pool (p  0.02). Faserl et al. concluded that the inability to
sufﬁciently activate phagocytic function ofmacrophages inwomen
with endometriosis may allow endometriotic tissues to implant in
the peritoneal cavity.
Many epidemiologic studies have linked vitamin D and an
increased prevalence of autoimmune disease [28–30]. Although
endometriosis has been considered an autoimmune disease, in
the present study we did not ﬁnd any association between VDR
polymorphisms and endometriosis-related infertility or idio-
pathic infertility. When we studied patients with minimal/mild
endometriosis and moderate/severe endometriosis separately,
no difference was found. The ﬁnding suggests that the VDR (ApaI,
TaqI, FokI, and BmsI) polymorphisms are not related to endome-
triosis pathogenesis in the Brazilian population. When we com-
pared infertile groups with and without endometriosis to deter-
mine whether the polymorphismwas linked to endometriosis or
infertility, there was no statistically signiﬁcant difference re-
lated to the frequencies of the studied polymorphisms, which
suggests that VDR polymorphisms are not related to infertility
risk in the Brazilian population.
A major limitation of our study is the relatively low number of
patients, which reduced the statistical power to detect associations
between the studied polymorphisms and unexplained female in-
fertility and/or endometriosis. However, the small number of stud-
ied patients is the result of selection criteria once all patients
included in this study were operated on using laparoscopy and
classiﬁed according to endometriosis stage with histologic conﬁr-
mation of the disease. None of the patients had a clinical history of
autoimmune disease.
In conclusion, the results suggest that VDR (ApaI, TaqI, FokI,
and BmsI) polymorphisms do not play a role in the pathogenesis
of idiopathic infertility and endometriosis-related infertility in
Brazilian women. However, the results do exclude a role ofvitamin D in endometriosis. Perhaps other polymorphisms and
mutations can act in the vitamin D inﬂuences the disease. It
would be of great interest to characterize the actual relation
between these mutations and endometriosis and/or infertility in
a large number of cases.
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